Overview
  • Transaction Name: Halozyme Therapeutics, Inc. / Antares Pharma, Inc.
  • Acquirer: Halozyme Therapeutics, Inc.
  • Target: Antares Pharma, Inc.
  • Announcement Date: April 13, 2022
  • Status: Pending
Loading...
  • of